Press Release Watch

SANTA CLARA, CA - The latest news and information from the oncology field along with industry events are now centralized in one, simple website. “The Buzz, Information Delivered” at www.crownbio.com/the-buzz highlights the latest updates in oncology in addition to providing information about leading oncology-CRO Crown Biosciences.

Crownbio.com/the-buzz is a one-stop resource through which those interested in the industry can get oncology knowledge, submit oncology case studies, highlight oncology events, and inform stakeholders of Crownbio’s recent advances. The page is divided into four sections:

•   Recent updates: A place to examine Crownbio’s extensive oncology collections to remain informed of new advances and results in clinical studies and trials.

•   Press news: A section that keeps all types of stakeholders up-to-date on the company’s new hires, published material by thought leaders, and facility expansions.

•   Event shows: A constantly-updated list of Crownbio-sponsored events for industry insiders to meet experts and learn about new advances in the oncology field.

•   Job postings: Job seekers can review and apply to job listings at Crownbio.

The new section of Crownbio’s site fulfills the company’s goal to surpass the competition through a website focusing on the process of scientific organization and workflow. The page extends the company’s brand and directs visitors back to the main site because of its richly-layered format. Crownbio is an industry leader in the life sciences and provides expert advice on preclinical oncology and related medical services.

Crown Bioscience is an oncology CRO that advances anti-cancer solutions through the clinical-trial process. The firm’s expert team combines services including: preclinical, translational, and clinical capabilities. Crownbio’s expertise accelerates an oncology product’s time to market.  Learn more about CRO oncology services from Crown Bio today.

This entry was posted on Friday, July 16th, 2010 at 8:06 am and is filed under B2B Products, B2B Services, BioPharma News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.